In the past decades the Council of Europe addressed a variety of developments in the field of biomedicine. While recognising these developments as a potential benefit for human health and welfare, the Council also realises the possibility of abuse as a reason for concern from the perspective of human rights and human dignity. On the basis of the common framework provided by the European Convention on Human Rights and Biomedicine, or Oviedo Convention (1997), the Committee on Bioethics of the Council of Europe (DH-BIO) has considered various ethical and legal challenges raised by the applications of biology and medicine.
In recent years innovations in the biomedical field are more and more emerging from the convergence of developments in different domains, including nanotechnology, cognitive science and information technology. As a result of this convergence, we can observe an increasing interaction between the life sciences and the engineering sciences. This interaction and convergence between different scientific and technological fields also raises new questions about the implications of these developments for human rights and human dignity.
For the DH-BIO, there is a clear need to look into these new developments in order to be able to respond to the possible ethical and legal challenges raised by these new technologies and their convergence.
Legal instruments and related documents
- Statement on genome editing technologies
- Ethical Issues Raised by Emerging Sciences and Technologies (University of Bergen, Norway)
- From Bio to NBIC convergence – From Medical Practice to Daily Life (Rathenau Institute, Netherlands)
- Report prepared by the Conference's rapporteurs
- Videos of the Emerging Technologies Conference
- Programme and abstracts of the Emerging Technologies Conference
- Video clip on emerging technologies
The DH-BIO adopted a Statement on Genome Editing Technologies during it's 8th meeting in Strasbourg on 2 December 2015. The scientific community is abuzz with discussion of the new technologies to modify genes such as CrisprCas9. “There is strong support for better understanding of causes of...
Watch video of the PACE debate "Manufacturing a New Human Species?" Mark Bale, Chair of the Committee on Bioethics (DH-BIO) participated in the debate on the use of genome editing technology (CRISPR-Cas9). The debate was organised by PACE on 30 September 2015 from 14.00 to 15.30. Interview of...
Convergence of emerging technologies, i.e. nano-, bio-, IT and cognitive technologies has opened new perspectives for progress, particularly in regards to human health. For instance, treating symptoms of Parkinson disease is possible due to deep brain stimulation; nanotechnologies combined with...